COVID-19: Why concerns over AstraZeneca jab are unlikely to derail UK's vaccine programme

The ongoing safety concerns about the AstraZeneca-Oxford vaccine do not seem to have crossed the channel. At least not yet. The possible link with a rare type of blood clot has been around for a few weeks now. Some governments in Europe have decided that they will not administer the jab to younger people. That is against the advice of the European Medicines Agency (EMA) and the World Health Organisation (WHO).